PATENT CLAIM ANALYSIS

Application Number: 15743601
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "157000"]

Abstract:
Disclosed herein are compounds having the following structure useful as inhibitors of carbonic anhydrase IX (CAIX) and XII, and particularly useful for reducing or eliminating metastases see Formula (I).

Claim (Index 10):
A compound of Formula (II): wherein: R 1  is alkyl, cycloalkyl, cycloalkylalkyl, haloalkyl, aryl, heterocyclyl, heteroaryl, or alkoxy; R 2 , R 3 , R 4 , and R 5  are the same or different and independently from hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, amino, halo, or haloalkyl; R 6 , R 7 , R 8 , and R 9  are the same or different and independently hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, amino, halo, or haloalkyl; L is a direct bond or)(C(R 10 ) 2 ) p ; n=1, 2 or 3; and p=1 to 4; each R 10  is the same or different and independently hydrogen or alkyl; a stereoisomer, enantiomer or tautomer thereof, an isotopically enriched derivative thereof, a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof or a prodrug thereof, provided that the compound of Formula (II) is not 4-[3-[cis-4-(aminomethyl)-3-(3-chlorophenyl)cyclohexyl]-2-oxo-1-imidazolidinyl]-benzenesulfonamide.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.12903
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14795837', '14355552', '13737704', '15631417', '12695636']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.788526108427542
- 35 USC 102 Novelty (BERT): 0.5007032915699253
- Combined Prediction Score: 0.7597438267417803
- Mean Citation Score: 267.4747
- Max Citation Score: 280.91833
- Similarity Product: 240.59597571848755

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test